A Randomized Trial of Prophylactic Extended Carboplatin Infusion to Reduce Hypersensitivity Reactions in Recurrent Ovarian Cancer-Reference-Cited by-同舟云学术

A Randomized Trial of Prophylactic Extended Carboplatin Infusion to Reduce Hypersensitivity Reactions in Recurrent Ovarian Cancer

Published:2018-07 Issue:6 Volume:28 Page:1176-1182
ISSN:1048-891X
Container-title:International Journal of Gynecological Cancer
language:en
Short-container-title:International Journal of Gynecological Cancer

Author:

LaVigne Katherine,Hyman David M.,Zhou Qin C.,Iasonos Alexia,Tew William P.,Aghajanian Carol,Makker Vicky,Hensley Martee L.,Konner Jason,Grisham Rachel N.,Cangemi Nicholas,Soldan Krysten,Spriggs David R.,Sabbatini Paul J.,OʼCearbhaill Roisin E.

Publisher

BMJ

Subject

Obstetrics and Gynecology,Oncology

Reference29 articles.

1. Continued Chemosensitivity to Cisplatin/Carboplatin in Ovarian Carcinoma Despite Treatment with Multiple Prior Platinum-Based Regimens

2. Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin.

3. The MITO8 phase III international multicenter randomized study testing the effect on survival of prolonging platinum-free interval (PFI) in patients with ovarian cancer (OC) recurring between 6 and 12 months after previous platinum-based chemotherapy: A collaboration of MITO, MANGO, AGO, BGOG, ENGOT, and GCIG.

4. Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial

5. Retrospective Analysis of Carboplatin and Paclitaxel as Initial Second-Line Therapy for Recurrent Epithelial Ovarian Carcinoma: Application Toward a Dynamic Disease State Model of Ovarian Cancer

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epithelial Ovarian Cancer;Tata Memorial Centre Textbook of Oncology;2024

2. The Rate of Infusion Represents an Important Aspect of Administering Anticancer Agents;Risk Management and Healthcare Policy;2023-11

3. Hypersensitivity Reactions to Platinum Agents and Taxanes;Clinical Reviews in Allergy & Immunology;2021-08-02

4. Hypersensitivity to platinum salts according to BRCA status in ovarian cancer: A retrospective analysis of clinical outcomes and systematic review of literature;Gynecologic Oncology;2021-07

5. PLATINUM HYPERSENSITIVITY REACTIONS, A FOCUS ON DESENSITISATION;FARMACIA;2021-06-28